glp 1 drugs and crohn's disease GLP-1 Receptor Agonists in Obese Patients with Inflammatory Bowel Disease: from Molecular Mechanisms to Clinical Considerations Practical Recommendations for Safe and Effective Use | Current Obesity Reports Ozempic and Crohn's Disease: Could
Description
More people achieved at least a 5% weight reduction, but the drug caused higher rates of mild-to-moderate gastrointestinal issues
Restaurant chains Chipotle and Shake Shack also mentioned GLP-1 users last month when they debuted new protein-heavy menu items
Warnings of phentermine and Ozempic Before taking phentermine or Ozempic, be sure to inform your healthcare provider about your medical conditions and family history
PMID: 47 DruckerDJRosenCF
2019:EJE-19-0566.R0561
While these drugs can deliver life-changing results, theyre not a one-size-fits-all solution
